A comparative study of inhaled ciclesonide 160 mcg/day vs budesonide 400 mcg/day in patients with asthma
Phase of Trial: Phase III
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Budesonide; Ciclesonide
- Indications Asthma
- Focus Therapeutic Use
- 04 May 2012 Takeda Global Research and Development Center added as company and lead trial centre as reported by ClinicalTrials.gov.
- 04 May 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 24 Nov 2005 New trial record.